Jean-Paul Clozel

$997.95M

as of 02/04/23

About Jean-Paul Clozel

Jean-Paul Clozel and his wife Martine Clozel cofounded Swiss biotech firm Actelion in 1997 with three other colleagues.

The husband-and-wife team sold the company to Johnson & Johnson for $30 billion in 2017.

Actelion makes drugs for orphan diseases, which affect fewer than 200,000 people and typically receive little research funding.

Following the Johnson & Johnson acquisition, the couple spun out publicly-traded Idorsia, which they now run together.

Idorsia is specializing in the discovery and development of small molecules to eventually develop drugs to treat insomnia, lupus and other diseases.

Personal stats

Citizenship

Switzerland

Source of wealth

pharmaceuticals

Residence

Basel, Switzerland

Marital status

Married

Birth date

04/03/55 (age 69)

Self-made

self-made

Jean-Paul Clozel’s fortune is worth

17K

troy ounces of gold

15K

median U.S. household

10K

median U.S. income

0.02%

U.S. credit card volume

0.004%

GDP of the United States

0.003%

United States debt

Net worth history

Annual ranking

Did you know?

Jean-Paul is a trained cardiologist and Martine is a trained pediatrician.

Net worth over time

Real-time ranking

Financial assets

SIX SWISS | IDIA-CH

Idorsia Ltd